Remove Health Policy Remove Industry Remove Life Science Remove Survey
article thumbnail

Healthcare AI investment will shift to these 5 areas in the next 2 years: survey

Henry Kotula

The majority of healthcare and life sciences executives (82%) want to see their organizations more aggressively adopt AI technology, according to a new survey from KPMG, an audit, tax and advisory services firm. And executives across industries are optimistic about the new administration in Washington, D.C., As the U.S.

article thumbnail

Thinking About Telehealth Through the Lens of Real Estate – Listening to JLL

Health Populi

If you made your living in commercial real estate — and especially, working with hospitals’ and health systems’ office space — would the concept of telehealth be freaking you out right now? If you heed the words of JLL’s 2022 Patient Consumer Survey , you’d chill (at least a bit).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Will Consumers Cross the Cost-and-Trust Chasm Between Prescription Drugs and Hospitals?

Health Populi

rank prescription drugs, lab tests, emergency room visits, dental and vision care, preventive services, chronic disease management and mental health care as the “most essential” health care services, according to the 2019 Survey of America’s Patients conducted by The Physicians Foundation. People in the U.S.

article thumbnail

A Public Health Wake-Up Call: Reading Between the Lines in IQVIA’s 2023 Use of Medicines Report

Health Populi

Here, we call out the 12% increase in the proportion of Americans who say that parents should be able to choose not to vaccinate their children, found in the Kaiser Family Foundation COVID-19 Vaccine Monitor survey from December 2022.

article thumbnail

The Remarkable Rise of Pharma’s Reputation in the Pandemic

Health Populi

The reputation of the pharmaceutical industry gained a “whopping” 30 points between January 2020 and February 2021, based on the latest Harris Poll in their research into industries’ reputations. consumers trusted the biotech health industry segment compared with the pharmaceutical segment.

article thumbnail

Most Americans Across Party ID Favor U.S. Government Negotiation to Lower Rx Drug Costs

Health Populi

KFF surveyed 1,440 adults 18 and over by phone between February 14th–24th 2019. Health Populi’s Hot Points: This week, Eli Lilly announced that they would introduce a generic form of Humalog , the company’s insulin product, at a price 50% lower than the brand.